SAT0088 Hdl cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis

MLA

José M. Olmos, et al. “SAT0088 Hdl Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients: Contributing Factors and Relationship with Subclinical Atherosclerosis.” Poster Presentations, June 2017. EBSCOhost, https://doi.org/10.1136/annrheumdis-2017-eular.4100.

APA

José M. Olmos, Alejandra González-Delgado, M. A. González-Gay, A Vera-González de, Iván Ferraz-Amaro, Jdm Machado, M Macía-Díaz, J.L. Hernández, Federico Díaz-González, & B. Tejera Segura. (2017). SAT0088 Hdl cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis. Poster Presentations. https://doi.org/10.1136/annrheumdis-2017-eular.4100

Chicago

José M. Olmos, Alejandra González-Delgado, M. A. González-Gay, A Vera-González de, Iván Ferraz-Amaro, Jdm Machado, M Macía-Díaz, J.L. Hernández, Federico Díaz-González, and B. Tejera Segura. 2017. “SAT0088 Hdl Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients: Contributing Factors and Relationship with Subclinical Atherosclerosis.” Poster Presentations, June. doi:10.1136/annrheumdis-2017-eular.4100.